Tardive Dyskinesia and Psychiatric Illness

Download All
Access these interactive, online programs designed to provide the care team with the resources and practical guidance they need to apply the most recent data, guidelines, and expert recommendations for the personalized treatment of their patients with tardive dyskinesia.
Leslie Citrome, MD, MPH
Rif S. El-Mallakh, MD
Joseph Goldberg, MD
Manish Kumar Jha, MD
John M. Kane, MD
Greg Mattingly, MD
Joseph P. McEvoy, MD
Roger McIntyre, MD, FRCPC
Jonathan M. Meyer, MD
Rebecca S. Roma, MD


Roger McIntyre, MD, FRCPC, and Joseph Goldberg, MD, discuss mood disorders, antipsychotics and tardive dyskinesia (TD).

Joseph Goldberg, MD Roger McIntyre, MD, FRCPC Released: May 24, 2021

Leslie Citrome, MD, MPH, and Joseph P. McEvoy, MD, discuss diagnosis of tardive dyskinesia (TD) in clinical practice.

Leslie Citrome, MD, MPH Joseph P. McEvoy, MD Released: June 11, 2021

John M. Kane, MD, and Rebecca S. Roma, MD, discuss the relationship of extrapyramidal symptoms, antiparkinsonian drugs, and tardive dyskinesia.

John M. Kane, MD Rebecca S. Roma, MD Released: July 20, 2021


The use of telemedicine to aid in the assessment of patients with tardive dyskinesia has emerged. Here are my key insights on how it could be used.

Joseph P. McEvoy, MD Released: May 4, 2021

Early recognition of signs and symptoms potentially associated with TD can lead to improved understanding of the diagnosis, consideration of treatment options, and better long-term patient outcomes. Here are my key insights on TD identification.

Rif S. El-Mallakh, MD Released: June 8, 2021

Anticholinergics improve parkinsonism but exacerbate TD, and VMAT2 inhibitors improve TD but do not treat parkinsonism and may worsen it. Jonathan Meyer, MD, explores this psychopharmacology topic and reflects on processes acting on different neurons.

Jonathan M. Meyer, MD Released: July 8, 2021

Downloadable Slidesets

Formulate an approach to select the right treatment for patients with tardive dyskinesia.

Manish Kumar Jha, MD Released: June 17, 2021

Formulate an approach to diagnose patients with tardive dyskinesia.

Greg Mattingly, MD Released: June 21, 2021
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@clinicaloptions.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant provided by
Neurocrine Biosciences

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.